Twin Lakes Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $171K | Hold |
1,615
| – | – | 0.1% | 85 |
|
|
2025
Q1 | $201K | Sell |
1,615
-300
| -16% | -$37.2K | 0.14% | 83 |
|
|
2024
Q4 | $236K | Sell |
1,915
-256
| -12% | -$31.5K | 0.15% | 77 |
|
|
2024
Q3 | $242K | Hold |
2,171
| – | – | 0.16% | 76 |
|
|
2024
Q2 | $232K | Hold |
2,171
| – | – | 0.16% | 77 |
|
|
2024
Q1 | $261K | Hold |
2,171
| – | – | 0.18% | 73 |
|
|
2023
Q4 | $267K | Sell |
2,171
-1,000
| -32% | -$123K | 0.18% | 70 |
|
|
2023
Q3 | $410K | Hold |
3,171
| – | – | 0.3% | 53 |
|
|
2023
Q2 | $393K | Hold |
3,171
| – | – | 0.28% | 58 |
|
|
2023
Q1 | $464K | Hold |
3,171
| – | – | 0.35% | 54 |
|
|
2022
Q4 | $505K | Sell |
3,171
-61
| -2% | -$9.72K | 0.39% | 49 |
|
|
2022
Q3 | $431K | Buy |
+3,232
| New | +$431K | 0.35% | 59 |
|
|
2022
Q2 | – | Sell |
-3,337
| Closed | -$519K | – | 217 |
|
|
2022
Q1 | $519K | Hold |
3,337
| – | – | 0.29% | 60 |
|
|
2021
Q4 | $425K | Hold |
3,337
| – | – | 0.23% | 67 |
|
|
2021
Q3 | $435K | Hold |
3,337
| – | – | 0.26% | 61 |
|
|
2021
Q2 | $593K | Hold |
3,337
| – | – | 0.33% | 49 |
|
|
2021
Q1 | $549K | Hold |
3,337
| – | – | 0.34% | 54 |
|
|
2020
Q4 | $551K | Buy |
+3,337
| New | +$551K | 0.39% | 51 |
|